Anzeige
Mehr »
Login
Sonntag, 23.02.2025 Börsentäglich über 12.000 News von 688 internationalen Medien
851 % Rendite in 30 Tagen: Die KI-Aktie, die seit der Integration von Deepseek R1 Wellen schlägt!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QCUH | ISIN: SE0014855029 | Ticker-Symbol: 8IM1
Tradegate
21.02.25
17:54 Uhr
3,250 Euro
-0,010
-0,31 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
IMPLANTICA AG SDR Chart 1 Jahr
5-Tage-Chart
IMPLANTICA AG SDR 5-Tage-Chart
RealtimeGeldBriefZeit
3,2253,28522.02.
3,2303,29021.02.

Aktuelle News zur IMPLANTICA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
14.02.Implantica publishes Year-end Report, January - December 2024 (Q4)199VADUZ, Liechtenstein, Feb. 14, 2025 /PRNewswire/ -- RefluxStop FDA Milestone Significant events in the fourth quarter Submitted extensive clinical Module 2 of the 3 module-process...
► Artikel lesen
13.02.Implantica announces positive feedback received from U.S. FDA of the RefluxStop PMA Module 2 submission256VADUZ, Liechtenstein, Feb. 13, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including a unique device RefluxStop...
► Artikel lesen
12.02.Implantica announces Module 1 is accepted and closed by FDA in the PMA application for RefluxStop1.494VADUZ, Liechtenstein, Feb. 12, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including a unique device RefluxStop...
► Artikel lesen
IMPLANTICA Aktie jetzt für 0€ handeln
07.02.Implantica presents the Year-end Report (Q4 2024) on February 14 at 15:00 CET243VADUZ, Liechtenstein, Feb. 7, 2025 /PRNewswire/ -- Implantica AG (publ) invites investors to a presentation of the Year-end Report (Q4 2024) at 15:00 CET on February 14. The Year-end Report...
► Artikel lesen
06.02.Implantica announces onboarding of the world-leading La Paz University Hospital, Spain168VADUZ, Liechtenstein, Feb. 6, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device...
► Artikel lesen
04.02.Implantica announces completion of first GI-focused RefluxStop educational meeting by a prestigious NHS Hospital in the UK201VADUZ, Liechtenstein, Feb. 4, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device...
► Artikel lesen
09.01.Implantica announces new exceptional published data from the largest real-world study from Germany391VADUZ, Liechtenstein, Jan. 9, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device...
► Artikel lesen
23.12.24Implantica announces the payment of share rewards based on the AGM approved share-based incentive program as a directed share issue of own shares of the company without consideration12
23.12.24Implantica to be included in Nasdaq's First North 25 index447VADUZ, Liechtenstein, Dec. 23, 2024 /PRNewswire/ -- Implantica AG (publ), a medtech company at the forefront of introducing advanced technology into the body, including the unique device...
► Artikel lesen
19.12.24Implantica strengthens the strategic RefluxStop expansion with the addition of yet another key University Hospital in Germany with several more in the pipeline383VADUZ, Liechtenstein, Dec. 19, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device...
► Artikel lesen
18.12.24Implantica announces two new RefluxStop University Hospitals in Spain, leading to 10 active centers and many more to join soon361VADUZ, Liechtenstein, Dec. 18, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device...
► Artikel lesen
17.12.24Implantica deepens market penetration in Italy with the addition of the ninth RefluxStop Center of Excellence and several lined up to start near-term477VADUZ, Liechtenstein, Dec. 17, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device...
► Artikel lesen
15.11.24Implantica publishes Interim Report January - September 2024 (Q3)440VADUZ, Liechtenstein, Nov. 15, 2024 /PRNewswire/ -- RefluxStop achieves crucial FDA milestone and leaps forward with strong momentum in both the US and Europe Significant events in the...
► Artikel lesen
14.11.24Implantica submits FDA PMA application Clinical Module 2 for RefluxStop for U.S. market approval375VADUZ, Liechtenstein, Nov. 14, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device...
► Artikel lesen
08.11.24Implantica presents the third quarter 2024 on November 15 at 15:00 CEST363VADUZ, Liechtenstein, Nov. 8, 2024 /PRNewswire/ -- Implantica AG (publ) invites investors to a presentation of the third quarter 2024 at 15:00 CET on November 15. The interim report for the...
► Artikel lesen
10.10.24Implantica announces highly successful 2024 American Foregut Society meeting where RefluxStop received remarkable pre-launch market feedback386VADUZ, Liechtenstein, Oct. 10, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, is pleased to report an impressive...
► Artikel lesen
10.10.24Implantica announces highly successful 2024 American Foregut Society meeting where RefluxStop® received remarkable pre-launch market feedback4
01.10.24Implantica welcomes 23 top anti-reflux surgeons from 17 leading centers in the first User meeting in Spain, 1.5 years post country launch311VADUZ, Liechtenstein, Oct. 1, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, announces that the first Spanish...
► Artikel lesen
25.09.24Implantica shares a landmark review article on standard of care Nissen Fundoplication anti-reflux surgery - in light of the recently announced excellent RefluxStop 5-year results443VADUZ, Liechtenstein, Sept. 25, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including a unique device...
► Artikel lesen
25.09.24Implantica announces finalization of remarkable 5-year pivotal CE mark study results and gears up for the Module 2 submission of PMA application to FDA for RefluxStop312VADUZ, Liechtenstein, Sept. 25, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including a unique device...
► Artikel lesen
Seite:  Weiter >>
44 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1